Table 1.
Demographic and clinical characteristics of the included participants.
| Participant | Gender | Age (months) | Epilepsy duration (months) | Age at onset (months) | Number of seizures | SWI |
|---|---|---|---|---|---|---|
| 1a | F | 106 | 5.8 | 100.2 | 4 | 50–60% |
| 2a | M | 86.1 | 5.8 | 80.3 | 2 | 55% |
| 3a | F | 105.5 | 2 | 103.5 | 2 | 65% |
| 4a | M | 103.2 | 4.4 | 98.8 | 3 | 60% |
| 5a | F | 97.2 | 24 | 73.2 | 5 | 65–70% |
| 6a | M | 72.6 | 8.3 | 64.3 | 1 | 70% |
| 7a | F | 82.4 | 2.5 | 79.9 | 6 | 70% |
| 8a | F | 112.5 | 12.5 | 100 | 2 | 50% |
| 9a | F | 116.3 | 2.6 | 113.7 | 2 | 50% |
| 10a | M | 95.9 | 3 | 92.9 | 3 | 60% |
| 11a | F | 117 | 2.5 | 114.5 | 2 | 65% |
| 12a | F | 91.8 | 2.2 | 89.6 | 1 | 50–60% |
| 13a | M | 85.4 | 8 | 77.4 | 2 | 60% |
| 14a | M | 85.2 | 1.1 | 84.1 | 2 | 50% |
| 15 | F | 84.8 | 12 | 82.8 | 2 | 40% |
| 16 | M | 120.6 | 12 | 108.6 | 3 | 30% |
| 17 | F | 132.8 | 24 | 108.8 | 2 | 30% |
| 18 | M | 114.5 | 5.4 | 109.1 | 5 | 35% |
| 19 | F | 73.5 | 4 | 69.5 | 4 | 30% |
| 20 | M | 101.5 | 1 | 100.5 | 2 | 30% |
| 21 | F | 99.5 | 4 | 95.5 | 2 | 25% |
| 22 | M | 107.3 | 9.3 | 98 | 1 | 40% |
| 23 | M | 85 | 1.8 | 83.2 | 1 | 20% |
| 24 | F | 99.4 | 0.6 | 98.8 | 1 | 20% |
| 25 | F | 74.6 | 0.7 | 73.9 | 1 | 40% |
| 26 | M | 131.8 | 0.6 | 131.2 | 3 | 30% |
| 27 | F | 96.9 | 0.6 | 96.3 | 1 | 10% |
| 28 | M | 135.8 | 18.4 | 117.4 | 1 | 10% |
| 29 | M | 110.8 | 10 | 100.8 | 2 | 15% |
| 30 | M | 76.8 | 2.8 | 74 | 4 | 25% |
| 31 | F | 113.3 | 0.4 | 112.9 | 2 | 40% |
| 32 | M | 77.5 | 0.3 | 77.2 | 2 | 40% |
| 33 | F | 99.4 | 0.6 | 98.8 | 1 | 20% |
| 34 | F | 101.1 | 0.3 | 100.8 | 1 | 40% |
| 35 | F | 117.4 | 0.9 | 116.5 | 1 | 35% |
SWI, spike-wave index; aSeLECTS (SWI ≥ 50%) group.